Profile data is unavailable for this security.
About the company
ImmunoPrecise Antibodies Ltd. is a Canada-based biotherapeutic research and technology company. It leverages systems biology, multiomics modelling and artificial intelligence systems to support its technologies in bioplatform-based antibody discovery. Its services include highly specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners to discover and develop novel biologics. It utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases. It offers services, such as immunogen design and manufacturing, B cell sorting incorporating its function-first B cell screening and sequencing, and the production and screening of custom, immune, and naive phage display libraries. It also operates LSA instrument platform, which is a provider of high-throughput large and small molecule screening and characterization solutions.
- Revenue in USD (TTM)17.34m
- Net income in USD-10.45m
- Incorporated2016
- Employees102.00
- LocationImmunoprecise Antibodies Ltd3204-4464 Markham StVICTORIA V8Z 7X8CanadaCAN
- Phone+1 (250) 483-0308
- Fax+1 (250) 483-0309
- Websitehttps://www.ipatherapeutics.com/
More ▼
Mergers & acquisitions
| Acquired company | IPA:NMQ since announced | Transaction value |
|---|---|---|
| Carterra Inc-LSA Platform | -19.31% | -- |
Data delayed at least 15 minutes, as of May 22 2024 20:55 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thiogenesis Therapeutics Corp | 0.00 | -3.71m | 24.71m | -- | -- | 5.96 | -- | -- | -0.1289 | -0.1289 | 0.00 | 0.1241 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Medipharm Labs Corp | 27.09m | -9.96m | 25.21m | 166.00 | -- | 0.6889 | -- | 0.9305 | -0.0382 | -0.0382 | 0.1017 | 0.1234 | 0.600 | 3.44 | 3.90 | 222,831.30 | -22.07 | -32.88 | -26.27 | -39.56 | 16.37 | -5.88 | -36.78 | -67.66 | 2.20 | -- | 0.0407 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
| Simply Better Brands Corp | 79.84m | -24.25m | 25.71m | -- | -- | -- | -- | 0.322 | -0.4616 | -0.4616 | 1.54 | -0.0684 | 2.84 | 6.79 | 22.87 | -- | -86.36 | -63.90 | -460.44 | -215.48 | 58.69 | -- | -30.37 | -29.46 | 0.298 | -8.19 | 1.65 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
| Medicus Pharma Ltd | 0.00 | -5.87m | 26.08m | -- | -- | 32.30 | -- | -- | -1.25 | -1.25 | 0.00 | 0.0681 | 0.00 | -- | -- | -- | -539.96 | -652.37 | -- | -- | -- | -- | -- | -- | -- | -7.90 | 0.00 | -- | -- | -- | -300.86 | -- | -- | -- |
| Eastwood Bio-Medical Canada Inc | 539.59k | -389.34k | 27.81m | -- | -- | -- | -- | 51.54 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -12.61m | 28.18m | 5.00 | -- | -- | -- | -- | -1.11 | -1.11 | 0.00 | -0.6896 | 0.00 | -- | -- | -- | -54.70 | -59.37 | -60.36 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Charlotte's Web Holdings Inc | 58.26m | -30.51m | 28.27m | 164.00 | -- | 0.6046 | -- | 0.4853 | -0.2716 | -0.2716 | 0.5182 | 0.4052 | 0.3668 | 1.07 | 27.08 | 485,053.90 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Medexus Pharmaceuticals Inc | 115.71m | 5.88m | 29.08m | 98.00 | 4.45 | 0.9818 | 2.48 | 0.2514 | 0.3637 | 0.3637 | 7.27 | 1.65 | 0.7547 | 2.19 | 5.44 | 1,612,120.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Immunoprecise Antibodies Ltd | 17.34m | -10.45m | 29.69m | 102.00 | -- | 0.8137 | -- | 1.71 | -0.4147 | -0.4147 | 0.6874 | 1.39 | 0.2939 | 5.25 | 6.76 | 170,046.20 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Decibel Cannabis Company Inc | 84.93m | -1.30m | 30.02m | -- | -- | 0.8854 | 30.59 | 0.3535 | -0.0045 | -0.0045 | 0.2739 | 0.1129 | 0.817 | 1.51 | 7.66 | -- | -1.25 | -3.55 | -2.04 | -5.19 | 36.10 | 38.83 | -1.53 | -7.13 | 0.3685 | 1.21 | 0.5122 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
| IntelGenx Technologies Corp. | 1.05m | -11.03m | 30.70m | 48.00 | -- | -- | -- | 29.21 | -0.0862 | -0.0862 | 0.0082 | -0.1201 | 0.1245 | 14.36 | 1.74 | -- | -130.62 | -75.15 | -- | -133.79 | -66.03 | -- | -1,049.48 | -819.85 | 0.1153 | -4.88 | 23.66 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |
| Microbix Biosystems Inc | 17.46m | 2.97m | 33.79m | 69.00 | 11.33 | 1.66 | 8.45 | 1.94 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
Data as of May 22 2024. Currency figures normalised to Immunoprecise Antibodies Ltd's reporting currency: US Dollar USD
6.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ingalls & Snyder LLCas of 13 Feb 2024 | 1.32m | 5.01% |
| BMO Asset Management Corp.as of 31 Mar 2024 | 53.81k | 0.20% |
| CIBC World Markets, Inc.as of 31 Mar 2024 | 41.20k | 0.16% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 37.60k | 0.14% |
| Susquehanna Financial Group LLLPas of 31 Mar 2024 | 32.99k | 0.13% |
| Northern Trust Global Investments Ltd.as of 31 Mar 2024 | 26.98k | 0.10% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 26.98k | 0.10% |
| Gradient Capital Advisors LLCas of 31 Mar 2024 | 26.81k | 0.10% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 23.35k | 0.09% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 22.03k | 0.08% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
